Annual ROE
-2546.09%
-2400.33%-1646.77%
December 31, 2022
Summary
- As of February 10, 2025, IMPL annual return on equity is -2546.09%, with the most recent change of -2400.33% (-1646.77%) on December 31, 2022.
- During the last 3 years, IMPL annual ROE has fallen by -2591.74% (-5677.42%).
Performance
IMPL ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly ROE
103.12%
-64.49%-38.48%
September 1, 2023
Summary
- As of February 10, 2025, IMPL quarterly return on equity is 103.12%, with the most recent change of -64.49% (-38.48%) on September 1, 2023.
- Over the past year, IMPL quarterly ROE has increased by +495.90% (+126.25%).
Performance
IMPL Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
ROE Formula
ROE = Net Income
Shareholders Equity ✕ 100%
Shareholders Equity ✕ 100%
IMPL ROE Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -1646.8% | +126.3% |
| 3 y3 years | -5677.4% | - |
| 5 y5 years | -5677.4% | - |
IMPL ROE Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | +1646.8% | at low | -68.1% | -3053.3% |
| 5 y | 5-year | -5677.4% | at low | -68.1% | -3053.3% |
| alltime | all time | -5677.4% | at low | -68.1% | -3053.3% |
Impel Pharmaceuticals ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2023 | - | 103.12%(-38.5%) |
| Jun 2023 | - | 167.61%(-48.1%) |
| Mar 2023 | - | 323.12%(-110.6%) |
| Dec 2022 | -2546.09% | -3045.49%(+675.4%) |
| Sep 2022 | - | -392.78%(+62.7%) |
| Jun 2022 | - | -241.46%(+35.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2022 | - | -178.04%(-79.5%) |
| Dec 2021 | -145.76%(-524.8%) | -867.68%(-596.8%) |
| Sep 2021 | - | 174.67%(+164.5%) |
| Jun 2021 | - | 66.05%(+93.9%) |
| Mar 2021 | - | 34.06%(-0.7%) |
| Dec 2020 | 34.31%(-24.8%) | 34.31% |
| Dec 2019 | 45.65% | - |
FAQ
- What is Impel Pharmaceuticals annual return on equity?
- What is the all time high annual ROE for Impel Pharmaceuticals?
- What is Impel Pharmaceuticals annual ROE year-on-year change?
- What is Impel Pharmaceuticals quarterly return on equity?
- What is the all time high quarterly ROE for Impel Pharmaceuticals?
- What is Impel Pharmaceuticals quarterly ROE year-on-year change?
What is Impel Pharmaceuticals annual return on equity?
The current annual ROE of IMPL is -2546.09%
What is the all time high annual ROE for Impel Pharmaceuticals?
Impel Pharmaceuticals all-time high annual return on equity is 45.65%
What is Impel Pharmaceuticals annual ROE year-on-year change?
Over the past year, IMPL annual return on equity has changed by -2400.33% (-1646.77%)
What is Impel Pharmaceuticals quarterly return on equity?
The current quarterly ROE of IMPL is 103.12%
What is the all time high quarterly ROE for Impel Pharmaceuticals?
Impel Pharmaceuticals all-time high quarterly return on equity is 323.12%
What is Impel Pharmaceuticals quarterly ROE year-on-year change?
Over the past year, IMPL quarterly return on equity has changed by +495.90% (+126.25%)